Hatter Horizon Series 2017

Please click on the thumbnail image to play the presentation.

The global burden of diabetes
Professor Paul Zimmet
Monash University, Melbourne, Australia

Therapy for the treatment of type 2 diabetes: out with the old and in with the new?
Professor Naveed Sattar
University of Glasgow, Scotland

The GLP-1 analogues & DPPIV Inhibitors – cardiovascular outcome benefits for some but not others?
Professor Nikolaus Marx
Aachen University, Germany

The sodium-glucose co-transporter inhibitors – a cardiologist’s perspective
Professor Lars Rydën
The Karolinska Institute, Stockholm, Sweden

Sweetening the urine: a new approach to the management of chronic kidney disease
Professor David Wheeler
Royal Free Hospital UCL, London, UK

Combination therapy – the way to go for cardioprotection
Dr Bob Ryder
City Hospital, Birmingham, UK

Leave a comment